Lerna Biopharma - About the company
Lerna Biopharma is a deadpooled company based in Singapore (Singapore), founded in 2020. It operates as a Provider of nucleic acid therapeutics leveraging chemistry and biological insights to deliver clinically meaningful treatments.. The company has 209 active competitors, including 68 funded and 62 that have exited. Its top competitors include companies like Alnylam, Sirnaomics and Drug Farm.
Company Details
Lerna Biopharma is a biotech company that focuses on nucleic acid therapeutics, specifically siRNA. They leverage their chemistry and biological insights to develop clinically meaningful treatments. They have sites in Singapore, China, and the USA.
- Website
- lernabio.com
- Email ID
- *****@lernabio.com
- Registered Address
- BEACH ROAD, Singapore, 199591
Key Metrics
Founded Year
2020
Location
Singapore, Singapore
Stage
Deadpooled
Investors
Ranked
190th among 209 active competitors
Employee Count
4 as on Apr 30, 2026
Legal entities associated with Lerna Biopharma
Lerna Biopharma is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
LERNA BIOPHARMA PTE. LTD. UEN: 202033416H , Singapore, Active | Oct 20, 2020 | - | - |
Sign up to download Lerna Biopharma's company profile
Lerna Biopharma's funding and investors
Lerna Biopharma is a funded company. Lerna Biopharma has 2 institutional investors.
View details of Lerna Biopharma's funding rounds and investors
Lerna Biopharma's founders and board of directors
Founder? Claim ProfileLerna Biopharma's employee count trend
Lerna Biopharma has 4 employees as of Apr 26. Here is Lerna Biopharma's employee count trend over the years:
Uncover Lerna Biopharma's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Lerna Biopharma's Competitors and alternates
Top competitors of Lerna Biopharma include Alnylam, Sirnaomics and Drug Farm. Here is the list of Top 10 competitors of Lerna Biopharma, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Alnylam 2002, Cambridge (United States), Public | Developer of RNA interference-based therapeutics for multiple disorders | $17M | 80/100 | |
2nd | Sirnaomics 2007, Gaithersburg (United States), Public | Developer of RNA based therapeutics for the treatment of cancer and fibrosis disease | $267M | 67/100 | |
3rd | Developer of a novel treatment for metabolic diseases | $138M | 65/100 | ||
4th | City Therapeutics 2006, Cambridge (United States), Series B | Developer of gene therapies for multiple diseases | $234M | 65/100 | |
5th |  Nimbus Therapeutics 2009, Cambridge (United States), Series F | Developer of targeted therapeutics for cancer, metabolic and inflammatory diseases | $637M | 65/100 | |
6th |  Mammoth 2017, Brisbane (United States), Series D | Provider of molecular diagnostics platform by using CRISPR technology | $271M | 64/100 | |
7th |  Mirum Pharmaceuticals 2018, Menlo Park (United States), Public | Developer of small molecule based therapeutics to treat rare diseases | $120M | 63/100 | |
8th |  Avidity Biosciences 2012, San Diego (United States), Acquired | RNA therapeutics innovator targeting muscle and other diseases with AOC platform | $143M | 63/100 | |
9th | OliX Pharmaceuticals 2010, Suwon-si (South Korea), Public | Developer of RNAi therapeutics for dermal, ophthalmic and pulmonary diseases. | - | 63/100 | |
10th |  Aligos Therapeutics 2018, San Francisco (United States), Public | Developer of therapies to treat hepatologic diseases and viral infections | $225M | 62/100 | |
190th |  Lerna Biopharma 2020, Singapore (Singapore), Deadpooled | Provider of nucleic acid therapeutics leveraging chemistry and biological insights to deliver clinically meaningful treatments. | - | 21/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Lerna Biopharma's competitors? Click here to see the top ones
Lerna Biopharma's Investments and acquisitions
Lerna Biopharma has made no investments or acquisitions yet.
Reports related to Lerna Biopharma
Here is the latest report on Lerna Biopharma's sector:
News related to Lerna Biopharma
•
Cargene Closes a US$19.2M Pre-A Round Led by BioTrack CapitalPR Newswire•Dec 14, 2021•Lerna Biopharma, BioTrack Capital, Hyfinity Investments, Legend Star and 1 other
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Lerna Biopharma
Explore our recently published companies
- Thinkflow Software - Palo Alto based, 2010 founded, Unfunded company
- Arka36T - Bengaluru based, 2025 founded, Unfunded company
- Aanya Wellness - Gurugram based, 2019 founded, Unfunded company
- Fitstok - Bengaluru based, 2023 founded, Unfunded company
- The Aleph Group - Singapore based, 2013 founded, Unfunded company
- TooliFyra - Delhi based, 2026 founded, Unfunded company
